(Q44345165)

2 December 2017

Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin (English)

1 reference

2 December 2017

0 references

Lawrence DM

1

1 reference

2 December 2017

Hutchinson I

2

1 reference

2 December 2017

Seyed-Mozaffari A

3

1 reference

2 December 2017

Archer S

4

1 reference

2 December 2017

Bidlack JM

5

1 reference

2 December 2017

1 February 1997

1 reference

Journal of Immunological Methods

2 December 2017

1 reference

2 December 2017

201

1 reference

2 December 2017

2

1 reference

2 December 2017

173-181

1 reference

Autofluorescence of viable cultured mammalian cells

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Leu-enkephalin binding to cultured human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

kappa-Opioid binding sites on a murine lymphoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Enantioselective kappa opioid binding sites on the macrophage cell line, P388d1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Delta opioid receptor gene expression in lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Expression of kappa opioid receptors in human and monkey lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Cloning of a delta opioid receptor by functional expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Opioid binding site in EL-4 thymoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Identification of kappa- and delta-opioid receptor transcripts in immune cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Fluorescent probes for opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Synthesis and pharmacological characterization of fluorescent opioid receptor probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Identification of kappa opioid receptors in the immune system by indirect immunofluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Binding of naloxone to human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Opiate receptors on lymphocytes and platelets in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Fluorescent phycobiliprotein conjugates for analyses of cells and molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Characterization of opiate binding sites on membranes of rat lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

[3H]morphine binding is enhanced by IL-1-stimulated thymocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Opioid peptides and opioid receptors in cells of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

Cloning and functional comparison of kappa and delta opioid receptors from mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2896%2900223-2

10.1016/S0022-1759(96)00223-2

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference